Galmed Pharmaceuticals (EOCN) Cash from Financing Activities (2013 - 2025)
Galmed Pharmaceuticals (EOCN) recorded Cash from Financing Activities of $1.19 million in Q4 2025, up 165.2% from $448,000 a year earlier and up 311.1% from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Cash from Financing Activities (2013 - 2025) Analysis & Trends
For FY2025, Galmed Pharmaceuticals reported Cash from Financing Activities of $9.03 million, up 2.7% from FY2024.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of 63.7% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $8.79 million in FY2024 (+42.1%), $6.19 million in FY2023, $70,000 in FY2022 (-99.6%) and $17.37 million in FY2021.
- Quarterly Cash from Financing Activities has ranged from $130,000 in Q1 2023 to $17.37 million in Q1 2021 over the past five years.
- Per Business Quant, the preceding three quarters came in at $289,000 (Q3 2025), $6.04 million (Q2 2025) and $1.51 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Galmed Pharmaceuticals | 406,071.97 | 406,071.97 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 289,000.00 |
| Jun 30, 2025 | 6.04 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 448,000.00 |
| Mar 31, 2023 | 130,000.00 |
| Mar 31, 2022 | 175,000.00 |
| Mar 31, 2021 | 17.37 Mn |
| Sep 30, 2020 | 707,000.00 |
| Mar 31, 2020 | 61,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Jun 30, 2019 | 21,000.00 |
| Mar 31, 2019 | 74,000.00 |
| Dec 31, 2018 | 115,000.00 |
| Sep 30, 2018 | 17,000.00 |
| Jun 30, 2018 | 80.03 Mn |
| Mar 31, 2018 | 12,000.00 |
| Dec 31, 2017 | 12.58 Mn |
| Sep 30, 2017 | 2.72 Mn |
| Sep 30, 2016 | 4.87 Mn |
API Access
Galmed Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();